Company / Total Debt
West Pharmaceutical Services Total Debt History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Debt
$202.8M
FY2025
5-year range
$202.6M / $253.0M
FY2021-FY2025
Trend
+0.1%
vs FY2024
Sector context
#78 of 100
Health Care
What the data says
West Pharmaceutical Services's total debt of $203M is lower than 78% of companies in the Health Care sector (FY2025). Total Debt returned to growth in FY2025 after 5 years of decline, reaching $203M.
Based on SEC 10-K filings.
$203M in FY2025 with a 5-year CAGR of -4.5%.
Remained stable around $203M over the past 2 years.
Health Care sector context is included.
Total Debt over time
Growth rates
- 3-Year CAGR
- -1.0%
- 5-Year CAGR
- -4.5%
- 10-Year CAGR
- -
Sector benchmark
Top 22% in Health CareTop 22% of 100This company $202.8M Sector average $4.6B
▼
-95.5% below sector average
Key checks
Key Insights
- 5-year CAGR of -4.5%, indicating a declining trend.
- In FY2025, total debt increased 0.1% year-over-year.
- Ranks #78 out of 100 companies in the Health Care sector.
- Peak total debt was recorded in FY2019.
Company context
Key Data Points
- Altman Z-Score 3.45 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total DebtValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $202.8M | +0.1% |
| FY2024 | $202.6M | -2.0% |
| FY2023 | $206.8M | -1.0% |
| FY2022 | $208.9M | -17.4% |
| FY2021 | $253.0M | -0.9% |
| FY2020 | $255.2M | -0.8% |
| FY2019 | $257.3M | +31.2% |
| FY2018 | $196.1M | -0.5% |
| FY2017 | $197.0M | -13.8% |
| FY2016 | $228.6M | -23.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026